scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.OPHTHA.2003.07.010 |
P698 | PubMed publication ID | 15051215 |
P2093 | author name string | Denis Wakefield | |
Ravi Singh | |||
John H Chang | |||
Peter McCluskey | |||
P433 | issue | 4 | |
P921 | main subject | methotrexate | Q422232 |
cicatricial pemphigoid | Q627291 | ||
P304 | page(s) | 796-801 | |
P577 | publication date | 2004-04-01 | |
P1433 | published in | Ophthalmology | Q7098109 |
P1476 | title | Methotrexate therapy for ocular cicatricial pemphigoid | |
P478 | volume | 111 |
Q36237529 | Autoimmune bullous diseases: ocular manifestations and management |
Q64898735 | Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology. |
Q92824372 | Dry Eye Disease: A Review of Epidemiology in Taiwan, and its Clinical Treatment and Merits |
Q58704407 | Efficacy and adverse reactions of methotrexate in the treatment of ocular cicatricial pemphigoid: A case series study |
Q24250186 | Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita |
Q37204512 | Methotrexate for ocular inflammatory diseases |
Q27691456 | Mucous membrane pemphigoid |
Q46661473 | Mucous membrane pemphigoid with ocular involvement. Part II: therapy |
Q64230980 | Ocular Mucous Membrane Pemphigoid: Current State of Pathophysiology, Diagnostics and Treatment |
Q53091231 | Ocular and oral grading of mucous membrane pemphigoid. |
Q36168693 | Ocular cicatricial pemphigoid: manifestations and management |
Q37264280 | Ocular mucous membrane pemphigoid: diagnosis and management strategies. |
Q49187320 | Successful treatment of mucous membrane pemphigoid with bortezomib |
Q39096598 | The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on. |
Q28067526 | The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature |
Q41359384 | Treatment strategies in mucous membrane pemphigoid |
Search more.